Kaveri Pohlman
Stock Analyst at BTIG
(0.19)
# 4,089
Out of 4,784 analysts
21
Total ratings
15%
Success rate
-32.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGNX MacroGenics | Downgrades: Neutral | n/a | $1.26 | - | 4 | Aug 1, 2024 | |
| GMAB Genmab | Maintains: Buy | $46 → $47 | $19.90 | +136.18% | 3 | Jun 27, 2024 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $20 → $30 | $8.02 | +274.06% | 2 | Apr 17, 2024 | |
| XNCR Xencor | Maintains: Buy | $56 → $38 | $11.23 | +238.38% | 1 | Apr 16, 2024 | |
| NUVB Nuvation Bio | Upgrades: Buy | $5 | $1.82 | +174.73% | 2 | Mar 26, 2024 | |
| JANX Janux Therapeutics | Initiates: Buy | $62 | $29.10 | +113.06% | 1 | Mar 21, 2024 | |
| PYXS Pyxis Oncology | Initiates: Buy | $8 | $1.06 | +654.72% | 1 | Feb 9, 2024 | |
| EXEL Exelixis | Initiates: Buy | $27 | $36.70 | -26.43% | 1 | Dec 19, 2023 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $70 | $8.17 | +756.79% | 1 | Aug 23, 2023 | |
| STTK Shattuck Labs | Initiates: Buy | $12 | $1.06 | +1,037.44% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $0.63 | +1,173.48% | 2 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12,320 → $4,928 | $1.31 | +376,083.21% | 2 | Feb 9, 2022 |
MacroGenics
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.26
Upside: -
Genmab
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $19.90
Upside: +136.18%
Cullinan Therapeutics
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $8.02
Upside: +274.06%
Xencor
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $11.23
Upside: +238.38%
Nuvation Bio
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $1.82
Upside: +174.73%
Janux Therapeutics
Mar 21, 2024
Initiates: Buy
Price Target: $62
Current: $29.10
Upside: +113.06%
Pyxis Oncology
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $1.06
Upside: +654.72%
Exelixis
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $36.70
Upside: -26.43%
Arcus Biosciences
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $8.17
Upside: +756.79%
Shattuck Labs
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $1.06
Upside: +1,037.44%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $0.63
Upside: +1,173.48%
Feb 9, 2022
Maintains: Buy
Price Target: $12,320 → $4,928
Current: $1.31
Upside: +376,083.21%